🇳🇬 PCN Licensed: LAG20247B39C9 📍 17 Ademola Osinowo Street, Ikosi Ketu, Lagos 📞 +234 705 050 5001 ✉ care@hubpharmafrica.com ⚡ Same-Day Delivery in Lagos 🌍 Serving patients in 31 countries 💊 10,200+ Chronic Care Patients ✅ NAFDAC & HIPAA Compliant 🇳🇬 PCN Licensed: LAG20247B39C9 📍 17 Ademola Osinowo Street, Ikosi Ketu, Lagos 📞 +234 705 050 5001 ✉ care@hubpharmafrica.com ⚡ Same-Day Delivery in Lagos 🌍 Serving patients in 31 countries 💊 10,200+ Chronic Care Patients ✅ NAFDAC & HIPAA Compliant

HomeOnline Pharmacy StoreInjection and InfusionAnti Rho-D Immunoglobulin Injection 300mcg

Anti Rho-D Immunoglobulin Injection 300mcg

Sale!

Anti Rho-D Immunoglobulin Injection 300mcg

Original price was: ₦126,000.00.Current price is: ₦117,600.00.

Anti D Rho 300mcg Injection is an immunoglobulin (also known as antibody). It helps in preventing antibodies from forming after a person with Rh-negative blood receives a transfusion with Rh-positive blood. It also helps during pregnancy when a mother has Rh-negative blood and the baby is Rh-positive.

Very secured payment methods
Shipping will be calculated on checkout
Please note that price may increase due to exchange rate, ensure updated price before making payment
Dispensing supervised byPharm. Tope Kareem, B.PharmSuperintendent Pharmacist and Co-founder, HubPharm Africa. Over 13 years in practice.PCN Reg. 023669
Last updated 28 August 2026How we write and check this informationPCN Premises Licence LAG20247B39C9

Description

Anti Rho-D Immunoglobulin Injection, also known as Rho(D) immune globulin, is a medication used to prevent Rh inization, a condition where an Rh-negative individual develops antibodies against Rh-positive blood cells. It is typically administered as an intramuscular injection and contains 300 micrograms (mcg) of anti-D antibodies.

Active Ingredient:

  • Rho(D) immune globulin: These are antibodies that specifically target and neutralize Rh-positive red blood cells, preventing the immune system from mounting an immune response against them.

Uses:

  1. Prevention of Hemolytic Disease of the Newborn (HDN):
    • During Pregnancy: Administered to Rh-negative pregnant women during and after pregnancy if there is a risk of fetal-maternal hemorrhage (e.g., after amniocentesis, miscarriage, or abdominal trauma).
    • Postpartum: Given within 72 hours after the birth of an Rh-positive baby to an Rh-negative mother to prevent the mother from developing antibodies that could affect future pregnancies.
Hi! I'm Afiya
Chat with me on WhatsApp - I speak Yoruba, Igbo, Hausa, Pidgin & 46 more languages!
Chat with Afiya AI
💊 Talk to a Pharmacist
Get expert medication advice from our licensed pharmacists - available 7 days a week!
Chat with our Pharmacist
Close